Area of research
Oncology · Molecular Biology
Research interest
Research interests include Medicine, Cancer research, Biology, Cancer, Breast cancer, and Gene.
Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma
Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
PTEN Loss Is Associated with Worse Outcome in <i>HER2</i> -Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance
Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes
Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer
Oncogenic ERBB3 Mutations in Human Cancers
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)
High Heregulin Expression Is Associated with Activated HER3 and May Define an Actionable Biomarker in Patients with Squamous Cell Carcinomas of the Head and Neck
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
Analysis of Fcγ Receptor IIIa and IIa Polymorphisms: Lack of Correlation with Outcome in Trastuzumab-Treated Breast Cancer Patients
Phase Ib Study of Drozitumab Combined With First-Line mFOLFOX6 Plus Bevacizumab in Patients with Metastatic Colorectal Cancer